Skip directly to content


GENOTROPIN has a long history of use. In 1995, GENOTROPIN was approved by the Food and Drug Administration (FDA) for the treatment of children with growth hormone deficiency (GHD).

Today, GENOTROPIN is FDA approved to treat the following growth disorders:

  • Children with growth hormone deficiency (GHD)
  • Children born small for gestational age (SGA)
  • Children with idiopathic short stature (ISS)*
  • Children with Prader-Willi syndrome (PWS)
  • Girls with Turner syndrome (TS)

GENOTROPIN is also FDA approved to treat:

  • Adults with growth hormone deficiency (GHD)

Talk to your doctor about whether GENOTROPIN is right for you.

Learn more about the growth disorders that GENOTROPIN treats


GENOTROPIN can be used to treat ISS only in children whose bones have not stopped growing. Other causes of short stature should be ruled out before GENOTROPIN is used.

Growth hormone should not be used in patients with Prader-Willi syndrome who are very overweight or have severe breathing problems.